The role of DAB2IP in androgen receptor activation during prostate cancer progression.
about
DAB2IP in cancerBiologic and clinical significance of androgen receptor variants in castration resistant prostate cancerSRC: marker or actor in prostate cancer aggressivenessAndrogen receptor phosphorylation: biological context and functional consequences.Tumor suppressor protein DAB2IP participates in chromosomal stability maintenance through activating spindle assembly checkpoint and stabilizing kinetochore-microtubule attachments.DAB2IP loss confers the resistance of prostate cancer to androgen deprivation therapy through activating STAT3 and inhibiting apoptosisThe role of epithelial plasticity in prostate cancer dissemination and treatment resistanceDOC-2/DAB2 interacting protein status in high-risk prostate cancer correlates with outcome for patients treated with radiation therapy.A Novel Monoclonal Antibody Against Human DAB2IP.Roles of Distal and Genic Methylation in the Development of Prostate Tumorigenesis Revealed by Genome-wide DNA Methylation AnalysisInfiltrating T cells promote renal cell carcinoma (RCC) progression via altering the estrogen receptor β-DAB2IP signals.Pretreatment biopsy analysis of DAB2IP identifies subpopulation of high-risk prostate cancer patients with worse survival following radiation therapyValidation of DAB2IP methylation and its relative significance in predicting outcome in renal cell carcinoma.RASAL2, a RAS GTPase-activating protein, inhibits stemness and epithelial-mesenchymal transition via MAPK/SOX2 pathway in bladder cancer.Are androgen receptor variants a substitute for the full-length receptor?Ras activation revisited: role of GEF and GAP systems.DAB2IP regulates cancer stem cell phenotypes through modulating stem cell factor receptor and ZEB1.Block one, unleash a hundred. Mechanisms of DAB2IP inactivation in cancer.microRNA-32 induces radioresistance by targeting DAB2IP and regulating autophagy in prostate cancer cells.Cytoplasmic gain-of-function mutant p53 contributes to inflammation-associated cancer.miR-889 promotes proliferation of esophageal squamous cell carcinomas through DAB2IP.Epigenetic Regulation in Prostate Cancer Progression.Association of rs3787016 in Long Non-coding RNAs POLR2E and rs2910164 in MiRNA-146a with Prostate Cancer: A Systematic Review and Meta-analysis.
P2860
Q26776456-C2B9D329-CCAA-4E02-A082-CEE8E3B35D26Q26858922-CF2CBAB3-8478-43CC-99C3-DEDEB6B2E13FQ27012541-24ACB9D8-8AF7-44E7-A963-D7D24A11865CQ30394055-5EC3EA65-487D-41A5-AA95-892130EEE343Q30822011-DF7CF45C-D4B0-45EB-BA94-C83364B6FF92Q33586771-8C0CD50C-048A-4F99-B1E9-98687C95F408Q34505037-4A6162E2-C721-42E1-89F9-60FCA273F16CQ35729485-D34A27A6-5354-4CF5-B089-31CF0C878B14Q36011799-07282904-C812-4307-A2CD-2F2354B5E5C0Q36628603-612C90E3-036D-4A9E-9D42-12A609691714Q36688972-4C522A91-0896-4661-8A47-BC3C4631438CQ37084855-2932F883-5A64-4E3D-A5C9-C182D3FD56F2Q37327806-8399C5D4-E718-4EB9-8CD3-0708D5A7B1A8Q37745314-B1D14ABC-9C94-44D0-AA78-8DDC5F3592DFQ38350089-17ECCD28-49F8-42AD-84C6-AFD14E0BFF98Q38381506-F627AFCA-596F-4BE3-B11C-F50E53998EAEQ38973690-95EB3851-07D3-402B-B685-6F485F65EBFDQ39012136-8672CDEE-B8E0-406B-9577-483A914383CBQ40257658-B348A99B-B4BC-4566-8895-FB57D90C4687Q42494742-8D12DE67-64D2-41B9-A235-8B1C0D337C12Q53557971-3DA44C58-8F62-47AA-9DC4-663E44E5FC9FQ54974720-5D471333-649F-4813-9819-FA9D5A84F0B1Q55220671-5A9CC3F4-9F3E-4E05-9CE6-316DCEF456DF
P2860
The role of DAB2IP in androgen receptor activation during prostate cancer progression.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
The role of DAB2IP in androgen receptor activation during prostate cancer progression.
@en
The role of DAB2IP in androgen receptor activation during prostate cancer progression.
@nl
type
label
The role of DAB2IP in androgen receptor activation during prostate cancer progression.
@en
The role of DAB2IP in androgen receptor activation during prostate cancer progression.
@nl
prefLabel
The role of DAB2IP in androgen receptor activation during prostate cancer progression.
@en
The role of DAB2IP in androgen receptor activation during prostate cancer progression.
@nl
P2093
P2860
P356
P1433
P1476
The role of DAB2IP in androgen receptor activation during prostate cancer progression.
@en
P2093
G Alexandrakis
P2860
P2888
P304
P356
10.1038/ONC.2013.143
P407
P577
2013-04-22T00:00:00Z
P5875
P6179
1035452052